MedTrace Logo

The Role of Adipokines In Atrial Fibrillation

NCT03592732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-02-01

No results posted yet for this study

Summary

The principal aim of the present study is to analyze adiponectin, omentin-1, apelin and visfatin plasma levels in patients with and without AF in an effort to identify their potential role in the development of AF.

Conditions

Interventions

OTHER

Blood sample

Blood sample

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Elias Sanidas, MD, PhD · Dept. of Cardiology, ESH Excellence Center, LAIKO General Hospital, Athens, Greece

Eligibility

Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-29
Primary Completion
2021-01-29
Completion
2021-01-29

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03592732 on ClinicalTrials.gov